Who are Upexi, Inc.'s main suppliers?

Upexi, Inc. (UPXI) key suppliers include: HIVEMIND-VALIDATION-MASTER-FUND, MFA-2510-MERCHANT-LLC, A-G-P-ALLIANCE-GLOBAL-PARTNERS. View the full supplier network at chainsifter.com/chain/UPXI.

Who are Upexi, Inc.'s major customers?

Upexi, Inc. (UPXI) key customers include: CYBERSYN-HOLDINGS-LLC, Johnson & Johnson, Johnson & Johnson, Mobiquity Technologies, Inc., Mobiquity Technologies, Inc. and 6 more. View the full customer network at chainsifter.com/chain/UPXI.

What sector is Upexi, Inc. in?

Upexi, Inc. (UPXI) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

UPXI Supply Chain: Upexi, Inc. Supplier List & 17 Relationships

3Suppliers

11Customers

3Debt Items

20Related Chains

Upexi, Inc. Suppliers

Ticker	Name	Confidence	Evidence
HIVEMIND-VALIDATION-MASTER-FUND	HIVEMIND-VALIDATION-MASTER-FUND	92%	the Company issued to the Investor a secured convertible promissory note in the original principal amount of approximately $36 million (the “Note”), in exchange for the transfer and contribution of 2…
MFA-2510-MERCHANT-LLC	MFA-2510-MERCHANT-LLC	92%	On April 1, 2024, the Company entered into a lease agreement with MFA 2510 Merchant LLC, which is owned by our CEO, Allan Marshall.
A-G-P-ALLIANCE-GLOBAL-PARTNERS	A-G-P-ALLIANCE-GLOBAL-PARTNERS	90%	the Company may offer and sell, from time to time, through the Sales Agent, shares of the Company’s common stock

Upexi, Inc. Customers

Ticker	Name	Confidence	Evidence
CYBERSYN-HOLDINGS-LLC	CYBERSYN-HOLDINGS-LLC	85%	. During the three months ended March 31, 2026, the Company disposed of fully amortized intangible assets with an original cost of approximately $ 9.6 million. As the intangible assets had no remaini…
JNJ	Johnson & Johnson	72%	al, Albert Einstein Medical Center, and Jeanes Hospital in Philadelphia. He has authored numerous peer reviewed journal articles and has given lectures throughout the country on various neurosurgical…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from UPXI graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from UPXI graph: Reciprocal relationship from JNJ grap…
MOBQ	Mobiquity Technologies, Inc.	72%	al, Albert Einstein Medical Center, and Jeanes Hospital in Philadelphia. He has authored numerous peer reviewed journal articles and has given lectures throughout the country on various neurosurgical…
MOBQ	Mobiquity Technologies, Inc.	72%	Reciprocal relationship from MOBQ graph: Reciprocal relationship from UPXI graph: al, Albert Einstein Medical Center, and Jeanes Hospital in Philadelphia. He has authored numerous peer reviewed journ…
CYGNET-ONLINE-LLC	CYGNET-ONLINE-LLC	62%	C 326 (“Financial Instruments – Credit Losses”) pertaining to “current expected credit losses. ASC 326 was adopted for fiscal year 2024 and did not have a material effect to the accompanying consolid…
E-CORE-E-CORE-TECHNOLOGY-INC	E-CORE-E-CORE-TECHNOLOGY-INC	62%	d intangible assets 1,549,212 Total assets transferred 4,051,462 Purchase price $ 6,000,000 Gain on sale of VitaMedica $ 1,948,538 Note 19. Discontinued Operations – Sale of E-Core E-Core, Technology…
E-CORE-HOLDINGS-LLC	E-CORE-HOLDINGS-LLC	62%	d intangible assets 1,549,212 Total assets transferred 4,051,462 Purchase price $ 6,000,000 Gain on sale of VitaMedica $ 1,948,538 Note 19. Discontinued Operations – Sale of E-Core E-Core, Technology…
E-CORE-TECHNOLOGY-INC	E-CORE-TECHNOLOGY-INC	62%	d intangible assets 1,549,212 Total assets transferred 4,051,462 Purchase price $ 6,000,000 Gain on sale of VitaMedica $ 1,948,538 Note 19. Discontinued Operations – Sale of E-Core E-Core, Technology…
GA-SOLUTIONS-LLC	GA-SOLUTIONS-LLC	62%	rchases products from the majority of the original vendors Cygnet was using at the time purchased Cygnet. In addition, it was determined by management that the goodwill related to Cygnet was complete…
NEW-ENGLAND-TECHNOLOGY-INC	NEW-ENGLAND-TECHNOLOGY-INC	62%	d intangible assets 1,549,212 Total assets transferred 4,051,462 Purchase price $ 6,000,000 Gain on sale of VitaMedica $ 1,948,538 Note 19. Discontinued Operations – Sale of E-Core E-Core, Technology…

Upexi, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
UPXI-DEBT	Debt stack $242.8M	90%	Market cache reports total debt of $242.8M.
UPXI-DEBT-13238	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2026-03-31.
UPXI-DEBT-13237	Warrants outstanding: 250000	90%	xbrl warrant detail from xbrl 2025-06-30.

Upexi, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Upexi, Inc..

Upexi, Inc. Ownership

Holder	Name	Confidence	Evidence
UPXI-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 57 tracked holders.

Upexi, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops
ABBV	AbbVie Inc.	100.00	2
ATON	AlphaTON Capital Corp	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
ADGM	Adagio Medical Holdings, Inc.	100.00	2
ANIK	Anika Therapeutics, Inc.	100.00	2
AURA	Aura Biosciences, Inc.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
TRIB	Trinity Biotech plc	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
ACIU	AC Immune SA	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
AORT	Artivion, Inc.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
ALC	Alcon Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
FDMT	4D Molecular Therapeutics, Inc.	100.00	2

Upexi, Inc. Supply Chain